Viking Therapeutics' stock declined by 37% following a downgrade to "hold" in December, anticipating competitive pressures from Novo Nordisk's CagriSema Phase 3 results. The company's GIP/GLP-1 ...

Knight Therapeutics Inc. GUD-T has signed a deal to buy the assets of Paladin Pharma Inc. as the Canadian drug company looks to build out its domestic business after a strategic push into South ...

Three months after an FDA approval for cancer immunotherapy Unloxcyt, Checkpoint Therapeutics has found a buyer. Sun Pharma has agreed to purchase the Massachusetts biotech for an upfront value of ...

MIRADOR, the new band co-founded by Greta Van Fleet’s Jake Kiszka and Ida Mae’s Chris Turpin, will expand their headlining tour to 31-dates due to popular demand. Tickets for all initial dates ...

"Sun Pharma")) and Checkpoint Therapeutics, Inc. (Nasdaq: CKPT) ("Checkpoint") today announced that they have entered into an agreement by which Sun Pharma will acquire Checkpoint, an ...

March 10 (Reuters) - India's Sun Pharmaceutical Industries (SUN.NS), opens new tab said on Monday it will acquire Checkpoint Therapeutics (CKPT.O), opens new tab, a U.S.-based immunotherapy and ...

Credit: Nils Versemann/Shutterstock. Sun Pharmaceutical Industries has agreed to acquire Checkpoint Therapeutics, a company specialising in immunotherapy and targeted oncology treatments, for an ...

And one startup, Xaira Therapeutics, took it a step further, expanding the industry’s definition of a megaround by reeling in a rarely seen $1 billion financing early in the year. In this week ...

NASHVILLE (CelebrityAccess) – Mirador, the new band co-founded by Greta Van Fleet’s Jake Kiszka and Ida Mae’s Chris Turpin, announce their first headlining tour of the US with shows in cities ...

Finally, Mirador Capital Partners LP increased its stake in shares of Zillow Group by 1.5% in the fourth quarter. Mirador Capital Partners LP now owns 19,955 shares of the financial services ...

--(BUSINESS WIRE)--Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company focused on the development of specialized cardiovascular therapeutics, with the late-stage asset ...